Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC BMS-191095 | 166095-21-2 | 98.0% | C22H21ClN4O2 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY14256100MG

Encompass_Preferred

BMS-191095 is a selective activator of mitochondrial ATP-sensitive potassium (mitoKATP) channels, inhibiting human platelet aggregation by opening mitochondrial K(ATP) channels. It induces mitochondrial depolarization of vascular smooth muscle (VSM) cells and dose-dependently induces vasodilation in endothelium-denuded cerebral arteries. BMS-191095 also reduces neuronal damage in rats with transient focal cerebral ischemia.

  • Induces mitochondrial depolarization of vascular smooth muscle (VSM) cells.
  • Dose-dependently induces vasodilation in endothelium denuded cerebral arteries.
  • Increases the frequency of calcium sparks in VSM cells.
  • Inhibits human platelet aggregation induced by collagen and thrombin.
  • Reduces neuronal damage in rats with transient focal cerebral ischemia.
  • Reduces total infarct volume and induces rapid mitochondrial depolarization in rats with ischemia.

Catalog No. 50-003-54711


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.